Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | PTPRC | P08575 | 1/20 | 0.50 |
| ▸ | PTPRG | P23470 | 1/20 | 0.50 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.49 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18214 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TP53KDM4EGLAMAPT | |
| Hydrochloric Acid SCHEMBL1631822 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TP53KDM4EGLAMAPT | |
| SCHEMBL10462650 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TP53KDM4EGLAMAPT | |
| 1,2-Dichloroethane SCHEMBL27883846 | 0.92 | ALDH1A1 (0.55) | ALDH1A1TP53KDM4EGLAMAPT | |
| SCHEMBL17494763 | 0.86 | ALDH1A1 (0.49) | ALDH1A1TP53KDM4EGLAMAPT | |
| SCHEMBL27299072 | 0.83 | ALDH1A1 (0.58) | ALDH1A1TP53KDM4EGLAMAPT | |
| SCHEMBL29989222 | 0.83 | TSHR (0.63) | ALDH1A1TP53KDM4EGLASORT1 | |
| SCHEMBL30356385 | 0.83 | ALDH1A1 (0.61) | ALDH1A1KDM4EGLAMAPTPOLB | |
| SCHEMBL28545012 | 0.83 | ALDH1A1 (0.61) | ALDH1A1KDM4EGLAMAPTPOLB | |
| SCHEMBL18163 | 0.83 | ALDH1A1 (0.61) | ALDH1A1KDM4EGLAMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739697-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zaklady Farmaceutyczne Polpharma S.A. (PL) | 2026-05-13 | — | — | EP | disclosed |
| EP-4389733-A4 | METHOD FOR PREPARING 5-BROMO-2-CHLORO-BENZOIC ACID AS RAW MATERIAL IN HYPOGLYCEMIC DRUG SYNTHESIS | ZHEJIANG AUSUN PHARMACEUTICAL CO LTD (CN) | 2025-08-27 | — | — | EP | disclosed |
| WO-2025088634-A1 | A PROCESS FOR THE PREPARATION OF GLIFLOZIN AGLYCONES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025056984-A1 | A NOVEL PROCESS FOR THE PREPARATION OF BEXAGLIFLOZIN A SGLT2 INHIBITOR AND ITS INTERMEDIATES THEREOF | VIJAYASRI ORGANICS PRIVATE LIMITED (IN) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025008539-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zakłady Farmaceutyczne POLPHARMA S.A. (PL) | 2025-01-09 | — | — | WO | disclosed |
| US-20240351970-A1 | PREPARATION METHOD OF 5-BROMO-2-CHLORO-BENZOIC ACID AS A SYNTHETIC RAW MATERIAL FOR HYPOGLYCEMIC DRUGS | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2024-10-24 | — | — | US | disclosed |
| US-20240351970-A1 | PREPARATION METHOD OF 5-BROMO-2-CHLORO-BENZOIC ACID AS A SYNTHETIC RAW MATERIAL FOR HYPOGLYCEMIC DRUGS | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2024-10-24 | — | — | US | disclosed |
| WO-2024182693-A1 | 2-AZASPIRO[3.3]HEPTANE DERIVATIVES AS STAT3 INHIBITORS FOR THE TREATMENT OF CANCER | VIVIDION THERAPEUTICS, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-4389733-A1 | METHOD FOR PREPARING 5-BROMO-2-CHLORO-BENZOIC ACID AS RAW MATERIAL IN HYPOGLYCEMIC DRUG SYNTHESIS | Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) | 2024-06-26 | — | — | EP | disclosed |
| WO-2023019849-A1 | METHOD FOR PREPARING 5-BROMO-2-CHLORO-BENZOIC ACID AS RAW MATERIAL IN HYPOGLYCEMIC DRUG SYNTHESIS | 浙江奥翔药业股份有限公司 | 2023-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240351970-A1 | PREPARATION METHOD OF 5-BROMO-2-CHLORO-BENZOIC ACID AS A SYNTHETIC RAW MATERIAL FOR HYPOGLYCEMIC DRUGS | GABRA5, DDC, GCG | ALDH1A1 1171/4885TP53 2351/4885KDM4E 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.